Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Clathrin-mediated endocytosis (CME) is a fundamental and highly conserved cellular process in eukaryotes responsible for the internalization of various cargo molecules—including transmembrane receptors, transporters, and nutrients—from the plasma membrane into the cell. This process involves the formation of clathrin-coated vesicles (CCVs), which are small membrane-bound structures enveloped by a protein coat primarily composed of clathrin. The CME machinery operates through several coordinated steps: Initiation, Coat Assembly, Maturation, Scission, and Uncoating. Key components include Clathrin, AP2 Complex, Accessory Proteins (Epsin, CALM/AP180, Eps15), Dynamin, and Hsc70 & Auxilin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clathrin-Mediated Endocytosis Machinery (None).